» Authors » Cecile Gaujoux-Viala

Cecile Gaujoux-Viala

Explore the profile of Cecile Gaujoux-Viala including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 2290
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruyssen-Witrand A, Dimeglio C, Nogue E, Molinary N, Pham T, Gaujoux-Viala C, et al.
Clin Exp Rheumatol . 2024 Oct; 42(11):2141-2149. PMID: 39436731
Objectives: To compare the humoral response after a SARS-CoV-2 infection in an inflammatory rheumatic disease population with a healthy control population in a case-control study. Methods: Cases: between March and...
2.
Fautrel B, Kedra J, Rempenault C, Juge P, Drouet J, Avouac J, et al.
Joint Bone Spine . 2024 Oct; 91(6):105790. PMID: 39389412
The French Society of Rheumatology recommendations for managing rheumatoid arthritis (RA) has been updated by a working group of 21 rheumatology experts, 4 young rheumatologists and 2 patient association representatives...
3.
Drouet J, Lopez-Medina C, Granger B, Fautrel B, Landewe R, Molto A, et al.
Rheumatol Int . 2024 Apr; 44(8):1455-1468. PMID: 38597981
Global health (GH) and health-related quality of life are patient priorities in axial spondyloarthritis (axSpA). Our objective was to assess the relative importance of disease-related factors including disease activity, and...
4.
Sepriano A, Ramiro S, van der Heijde D, Molto A, Gaujoux-Viala C, Dougados M, et al.
Semin Arthritis Rheum . 2024 Mar; 66:152424. PMID: 38479110
Objectives: To compare the long-term outcomes of three phenotypes of axial SpA (axSpA). Methods: Patients with a clinical diagnosis of axSpA from the DESIR cohort were grouped into three phenotypes...
5.
Bernard J, Barnetche T, Amory C, Despres J, Vandersmissen M, Landrin J, et al.
RMD Open . 2024 Jan; 10(1). PMID: 38216286
Objective: To evaluate the prevalence of symptoms and factors associated with irritable bowel syndrome (IBS) in axial spondyloarthritis (ax-SpA). Methods: In a cross-sectional multicentric study, consecutive patients with ax-SpA treated...
6.
Kedra J, Dieude P, Giboin C, Marotte H, Salliot C, Schaeverbeke T, et al.
Arthritis Rheumatol . 2023 Nov; 76(4):541-552. PMID: 37942714
Objective: We assess the clinical and structural impact at two years of progressively spacing tocilizumab (TCZ) or abatacept (ABA) injections versus maintenance at full dose in patients with rheumatoid arthritis...
7.
Gaujoux-Viala C, Bergmann J, Goguillot M, Melaine A, Guerin M, Edouard A, et al.
RMD Open . 2023 Nov; 9(4). PMID: 37914177
Objectives: The emergence of targeted therapy is changing rheumatoid arthritis (RA) management, but real-world data remain limited. This study aimed to describe real-world RA treatment patterns using data from a...
8.
Eymard F, Foltz V, Chemla C, Gandjbakhch F, Etchepare F, Fautrel B, et al.
Joint Bone Spine . 2022 Mar; 89(4):105370. PMID: 35248736
Objectives: To assess the interest of MRI and ultrasonography (US) in identifying early and advanced interphalangeal (IP) OA. Methods: We conducted a case-control study including patients with symptomatic hand OA...
9.
Holubar J, Broner J, Arnaud E, Halle O, Mura T, Chambert B, et al.
J Intern Med . 2022 Jan; 291(6):856-863. PMID: 35018669
Background: Inflammation of unknown origin (IUO) is a challenging situation in internal medicine. Objectives: To describe the final diagnoses in IUO and assess the helpfulness of F-fluorodesoxyglucose positron emission tomography...
10.
Beltai A, Combe B, Coffy A, Gaujoux-Viala C, Lukas C, Saraux A, et al.
Joint Bone Spine . 2021 Dec; 89(3):105326. PMID: 34906696
Objective: Multimorbidity is frequent in rheumatoid arthritis (RA) and could interfere with the therapeutic response. The aim of this study was to evaluate multimorbidity in the French cohort of early...